{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:44:41Z","timestamp":1784036681311,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10157-024-02468-9","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T08:02:17Z","timestamp":1709107337000},"page":"513-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cell division cycle 42 attenuates high glucose-treated renal tubular epithelial cell apoptosis, fibrosis, and inflammation, but activates the PAK1\/AKT pathway"],"prefix":"10.1007","volume":"28","author":[{"given":"Shanshan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuwen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6991-3264","authenticated-orcid":false,"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"issue":"4","key":"2468_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","volume":"107","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107(4):689\u2013705. https:\/\/doi.org\/10.1016\/j.mcna.2023.03.004.","journal-title":"Med Clin North Am"},{"key":"2468_CR2","doi-asserted-by":"publisher","unstructured":"Pelle MC, Provenzano M, Busutti M, Porcu CV, Zaffina I, Stanga L, et al. Up-date on diabetic nephropathy. Life (Basel). 2022;12(8). https:\/\/doi.org\/10.3390\/life12081202.","DOI":"10.3390\/life12081202"},{"issue":"2","key":"2468_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1570161117666190502103733","volume":"18","author":"C Faselis","year":"2020","unstructured":"Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of Type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117\u201324. https:\/\/doi.org\/10.2174\/1570161117666190502103733.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"2468_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","volume":"18","author":"J Barrera-Chimal","year":"2022","unstructured":"Barrera-Chimal J, Lima-Posada I, Bakris GL, Jaisser F. Mineralocorticoid receptor antagonists in diabetic kidney disease\u2014mechanistic and therapeutic effects. Nat Rev Nephrol. 2022;18(1):56\u201370. https:\/\/doi.org\/10.1038\/s41581-021-00490-8.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"2468_CR5","first-page":"751","volume":"99","author":"K McGrath","year":"2019","unstructured":"McGrath K, Edi R. Diabetic kidney disease: diagnosis, treatment, and prevention. Am Fam Physician. 2019;99(12):751\u20139.","journal-title":"Am Fam Physician"},{"key":"2468_CR6","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449. https:\/\/doi.org\/10.1155\/2021\/1497449.","journal-title":"Biomed Res Int"},{"issue":"Suppl 2","key":"2468_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ndt\/gfab045","volume":"36","author":"SC Tye","year":"2021","unstructured":"Tye SC, Denig P, Heerspink HJL. Precision medicine approaches for diabetic kidney disease: opportunities and challenges. Nephrol Dial Transplant. 2021;36(Suppl 2):3\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfab045.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2468_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/joim.13424","volume":"291","author":"M Guedes","year":"2022","unstructured":"Guedes M, Pecoits-Filho R. Can we cure diabetic kidney disease? Present and future perspectives from a nephrologist\u2019s point of view. J Intern Med. 2022;291(2):165\u201380. https:\/\/doi.org\/10.1111\/joim.13424.","journal-title":"J Intern Med"},{"issue":"2","key":"2468_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248\u201360. https:\/\/doi.org\/10.1016\/j.kint.2022.05.012.","journal-title":"Kidney Int"},{"key":"2468_CR10","doi-asserted-by":"publisher","unstructured":"Huang QY, Lai XN, Qian XL, Lv LC, Li J, Duan J, et al. Cdc42: a novel regulator of insulin secretion and diabetes-associated diseases. Int J Mol Sci. 2019;20(1). https:\/\/doi.org\/10.3390\/ijms20010179.","DOI":"10.3390\/ijms20010179"},{"key":"2468_CR11","doi-asserted-by":"publisher","unstructured":"Mosaddeghzadeh N, Ahmadian MR. The RHO Family GTPases: mechanisms of regulation and signaling. Cells. 2021;10(7). https:\/\/doi.org\/10.3390\/cells10071831.","DOI":"10.3390\/cells10071831"},{"issue":"3","key":"2468_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.51","volume":"7","author":"Z Huang","year":"2016","unstructured":"Huang Z, Zhang L, Chen Y, Zhang H, Zhang Q, Li R, et al. Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp\/stress fibers\/YAP pathway. Cell Death Dis. 2016;7(3): e2142. https:\/\/doi.org\/10.1038\/cddis.2016.51.","journal-title":"Cell Death Dis"},{"key":"2468_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905703","volume":"13","author":"S Jiang","year":"2022","unstructured":"Jiang S, Xu CM, Yao S, Zhang R, Li XZ, Zhang RZ, et al. Cdc42 upregulation under high glucose induces podocyte apoptosis and impairs beta-cell insulin secretion. Front Endocrinol (Lausanne). 2022;13: 905703. https:\/\/doi.org\/10.3389\/fendo.2022.905703.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2468_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/path.4508","volume":"236","author":"J Lin","year":"2015","unstructured":"Lin J, Shi Y, Peng H, Shen X, Thomas S, Wang Y, et al. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy. J Pathol. 2015;236(1):30\u201340. https:\/\/doi.org\/10.1002\/path.4508.","journal-title":"J Pathol"},{"issue":"2","key":"2468_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.4764","volume":"240","author":"J Shen","year":"2016","unstructured":"Shen J, Wang R, He Z, Huang H, He X, Zhou J, et al. NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes. J Pathol. 2016;240(2):149\u201360. https:\/\/doi.org\/10.1002\/path.4764.","journal-title":"J Pathol"},{"key":"2468_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101813","volume":"38","author":"HJ Sun","year":"2021","unstructured":"Sun HJ, Xiong SP, Cao X, Cao L, Zhu MY, Wu ZY, et al. Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-kappaB and STAT3. Redox Biol. 2021;38: 101813. https:\/\/doi.org\/10.1016\/j.redox.2020.101813.","journal-title":"Redox Biol"},{"key":"2468_CR17","doi-asserted-by":"publisher","unstructured":"Nakamichi R, Hayashi K, Itoh H. Effects of high glucose and lipotoxicity on diabetic podocytes. Nutrients. 2021;13(1). https:\/\/doi.org\/10.3390\/nu13010241.","DOI":"10.3390\/nu13010241"},{"key":"2468_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne). 2022;13: 816400. https:\/\/doi.org\/10.3389\/fendo.2022.816400.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7\u20138","key":"2468_CR19","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1002\/jcp.29512","volume":"235","author":"L Li","year":"2020","unstructured":"Li L, Xu L, Wen S, Yang Y, Li X, Fan Q. The effect of lncRNA-ARAP1-AS2\/ARAP1 on high glucose-induced cytoskeleton rearrangement and epithelial-mesenchymal transition in human renal tubular epithelial cells. J Cell Physiol. 2020;235(7\u20138):5787\u201395. https:\/\/doi.org\/10.1002\/jcp.29512.","journal-title":"J Cell Physiol"},{"issue":"9","key":"2468_CR20","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1681\/ASN.2012121236","volume":"24","author":"SY Choi","year":"2013","unstructured":"Choi SY, Chacon-Heszele MF, Huang L, McKenna S, Wilson FP, Zuo X, et al. Cdc42 deficiency causes ciliary abnormalities and cystic kidneys. J Am Soc Nephrol. 2013;24(9):1435\u201350. https:\/\/doi.org\/10.1681\/ASN.2012121236.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2468_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yexcr.2017.07.018","volume":"359","author":"X Zhang","year":"2017","unstructured":"Zhang X, Liu Y, Shao R, Li W. Cdc42-interacting protein 4 silencing relieves pulmonary fibrosis in STZ-induced diabetic mice via the Wnt\/GSK-3beta\/beta-catenin pathway. Exp Cell Res. 2017;359(1):284\u201390. https:\/\/doi.org\/10.1016\/j.yexcr.2017.07.018.","journal-title":"Exp Cell Res"},{"key":"2468_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ebiom.2019.10.060","volume":"50","author":"C Liu","year":"2019","unstructured":"Liu C, Zhang L, Cui W, Du J, Li Z, Pang Y, et al. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1\/Cdc42-PAK signalling pathway. EBioMedicine. 2019;50:122\u201334. https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.060.","journal-title":"EBioMedicine"},{"key":"2468_CR23","doi-asserted-by":"publisher","unstructured":"Ma X, Liu H, Zhu J, Zhang C, Peng Y, Mao Z, et al. miR-185\u20135p Regulates inflammation and phagocytosis through CDC42\/JNK pathway in macrophages. Genes (Basel). 2022;13(3). https:\/\/doi.org\/10.3390\/genes13030468.","DOI":"10.3390\/genes13030468"},{"key":"2468_CR24","doi-asserted-by":"publisher","unstructured":"Murshid A, Gong J, Prince T, Borges TJ, Calderwood SK. Scavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activation. PLoS One. 2015;10(4):e0122529. https:\/\/doi.org\/10.1371\/journal.pone.0122529.","DOI":"10.1371\/journal.pone.0122529"},{"issue":"10","key":"2468_CR25","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00125-016-4042-0","volume":"59","author":"M Ahn","year":"2016","unstructured":"Ahn M, Yoder SM, Wang Z, Oh E, Ramalingam L, Tunduguru R, et al. The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets. Diabetologia. 2016;59(10):2145\u201355. https:\/\/doi.org\/10.1007\/s00125-016-4042-0.","journal-title":"Diabetologia"},{"issue":"17","key":"2468_CR26","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1128\/MCB.00636-12","volume":"32","author":"T Ijuin","year":"2012","unstructured":"Ijuin T, Takenawa T. Regulation of insulin signaling by the phosphatidylinositol 3,4,5-triphosphate phosphatase SKIP through the scaffolding function of Pak1. Mol Cell Biol. 2012;32(17):3570\u201384. https:\/\/doi.org\/10.1128\/MCB.00636-12.","journal-title":"Mol Cell Biol"},{"key":"2468_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","volume":"72","author":"GM Bokoch","year":"2003","unstructured":"Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem. 2003;72:743\u201381. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161742.","journal-title":"Annu Rev Biochem"},{"issue":"46","key":"2468_CR28","doi-asserted-by":"publisher","first-page":"32565","DOI":"10.1074\/jbc.274.46.32565","volume":"274","author":"FT Zenke","year":"1999","unstructured":"Zenke FT, King CC, Bohl BP, Bokoch GM. Identification of a central phosphorylation site in p21-activated kinase regulating autoinhibition and kinase activity. J Biol Chem. 1999;274(46):32565\u201373. https:\/\/doi.org\/10.1074\/jbc.274.46.32565.","journal-title":"J Biol Chem"},{"key":"2468_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.696542","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jin D, Kang X, Zhou R, Sun Y, Lian F, et al. Signaling pathways involved in diabetic renal fibrosis. Front Cell Dev Biol. 2021;9: 696542. https:\/\/doi.org\/10.3389\/fcell.2021.696542.","journal-title":"Front Cell Dev Biol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-024-02468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-024-02468-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-024-02468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:03:56Z","timestamp":1716458636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-024-02468-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2468"],"URL":"https:\/\/doi.org\/10.1007\/s10157-024-02468-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}